Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07279987Not ApplicableNot Yet Recruiting

Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions

Role: lead

NCT07020858Recruiting

FAPI Imaging Predicts Adverse Cardiac Events in Chronic Total Occlusion

Role: lead

NCT06655922Recruiting

FAPI Imaging Assessment of Chronic Total Occlusion

Role: lead

NCT05623995Phase 4Unknown

Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)

Role: lead

NCT05614180Unknown

Chronic Total Occlusive Lesions CMR Study

Role: lead

All 5 trials loaded